Cabometyx 20 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBQ2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,975
Award facts
- Contract value 100% obligated
- $16,974.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units) with a ceiling value of $16,974.59 and an ultimate completion date of December 9, 2025. This delivery order was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the awardee based on its established performance as a critical supplier within the federal pharmaceutical supply chain and its specialization in distributing comprehensive pharmaceutical products and medical consumables to the Department of Defense.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at up to $499.999 billion through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion federal acquisition strategy designed to establish regional prime vendor contractors to supply branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. As one of multiple prime vendors under this program structure, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and the capability to fulfill diverse and specialized pharmaceutical requirements for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FFBQ2?
SPE2DR26FFBQ2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FFBQ2 worth?
The government has obligated $16,975 on SPE2DR26FFBQ2.
Is contract SPE2DR26FFBQ2 an order under another contract?
Yes. SPE2DR26FFBQ2 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBQ2 competed?
The extent of competition for SPE2DR26FFBQ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award